The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance

BACKGROUND: Anxiety disorders are highly prevalent and chronic disorders with treatment resistance to current pharmacotherapies occurring in approximately one in three patients. It has been postulated that flumazenil (FMZ) is efficacious in the management of anxiety disorders via the removal of α(4)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Alexander T, Addis, Stephen, Martyn, Vlad, Ramanathan, Hishani, Wilkerson, Grace K, Bennett, Kellie S, Hood, Sean D, Stampfer, Hans, Hulse, Gary K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021101/
https://www.ncbi.nlm.nih.gov/pubmed/36937113
http://dx.doi.org/10.1177/20451253231156400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021101/
https://www.ncbi.nlm.nih.gov/pubmed/36937113
http://dx.doi.org/10.1177/20451253231156400

Ejemplares similares